Dr. Stuart Titus to be one of 65 cannabis experts to speak on cannabis and CBD at special public hearing to determine how to regulate products containing cannabis and its derivatives.
The U.S. Food & Drug Administration will be holding a public hearing to gather opinions on legalizing CBD from cannabis experts and advocates later this month. The FDA will consider these opinions as the agency creates its framework to regulate the marketing of cannabis and cannabis-derived products, including the use of CBD in dietary supplements and foods.
Medical Marijuana, Inc. CEO Dr. Stuart Titus has been invited to speak during this public hearing to share his extensive expertise he has gathered from his years in the medical cannabis and CBD spaces.
Under Dr. Titus’s tenure as CEO and president of Medical Marijuana, Inc., our portfolio of companies have created dozens of new consumer CBD…